We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,600 results
  1. The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies

    The metastasis of melanoma cells to regional lymph nodes and distant sites is an important contributor to cancer-related morbidity and mortality...

    Azadeh Rahimi, Zahra Malakoutikhah, ... Shaghayegh Haghjooy Javanmard in Cancer Cell International
    Article Open access 06 December 2023
  2. Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions

    Background

    Recently, allogeneic natural killer (NK) cells have gained considerable attention as promising immunotherapeutic tools due to their unique...

    Daun Jung, Young Seok Baek, ... Hee Jung An in Journal of Experimental & Clinical Cancer Research
    Article Open access 23 October 2021
  3. Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer

    Background

    Identifying the target of natural killer (NK) cells in colorectal cancer (CRC) is critical for optimising the clinical use of NK...

    Lin Yang, Jiahong Yi, ... Liang** **a in British Journal of Cancer
    Article 25 May 2024
  4. Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients

    Background

    Natural killer (NK) cells-based therapies are one of the most promising strategies against cancer. The aim of this study is to investigate...

    Chenglong Li, Fangkun Liu, ... Yu Zeng in BMC Cancer
    Article Open access 02 March 2022
  5. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy

    Great strides have been made in recent years towards understanding the roles of natural killer (NK) cells in immunity to tumours and viruses. NK...

    Natalie K. Wolf, Djem U. Kissiov, David H. Raulet in Nature Reviews Immunology
    Article 30 May 2022
  6. Distinct developmental pathways generate functionally distinct populations of natural killer cells

    Natural killer (NK) cells function by eliminating virus-infected or tumor cells. Here we identified an NK-lineage-biased progenitor population,...

    Yi Ding, Marieke Lavaert, ... Avinash Bhandoola in Nature Immunology
    Article 13 June 2024
  7. The TNFα/TNFR2 axis mediates natural killer cell proliferation by promoting aerobic glycolysis

    Natural killer (NK) cells are predominant innate lymphocytes that initiate the early immune response during infection. NK cells undergo a metabolic...

    Abrar Ul Haq Khan, Alaa Kassim Ali, ... Seung-Hwan Lee in Cellular & Molecular Immunology
    Article Open access 09 August 2023
  8. CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma

    Background

    Glioblastoma (GBM) is the most common malignant brain tumor and has “immunologically cold” features. Changing GBM to an “immunologically...

    Tsutomu Nakazawa, Takayuki Morimoto, ... Takahiro Tsujimura in Journal of Experimental & Clinical Cancer Research
    Article Open access 10 August 2023
  9. Identification, sorting and profiling of functional killer cells via the capture of fluorescent target-cell lysate

    Assays for assessing cell-mediated cytotoxicity are largely target-cell-centric and cannot identify and isolate subpopulations of cytotoxic effector...

    Yen Hoon Luah, Tong** Wu, Lih Feng Cheow in Nature Biomedical Engineering
    Article 31 August 2023
  10. Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver

    Obesity is a major risk factor for cancers including hepatocellular carcinoma (HCC) that develops from a background of non-alcoholic fatty liver...

    Wenshu Tang, **gying Zhou, ... Alfred S. L. Cheng in Cellular & Molecular Immunology
    Article 20 May 2022
  11. Directly reprogrammed natural killer cells for cancer immunotherapy

    Efficacious and accessible sources of natural killer (NK) cells would widen their use as immunotherapeutics, particularly for solid cancers. Here, we...

    Han-Seop Kim, Jae Yun Kim, ... Yee Sook Cho in Nature Biomedical Engineering
    Article 02 August 2021
  12. Diversity of group 1 innate lymphoid cells in human tissues

    Group 1 innate lymphoid cells (ILC1s) are cytotoxic and interferon gamma-producing lymphocytes lacking antigen-specific receptors, which include...

    Natalia Jaeger, Alina Ulezko Antonova, ... Marco Colonna in Nature Immunology
    Article 02 July 2024
  13. Multifaceted characterization of the biological and transcriptomic signatures of natural killer cells derived from cord blood and placental blood

    Background

    Perinatal blood including umbilical cord blood and placental blood are splendid sources for allogeneic NK cell generation with high...

    Haibo Gao, Min Liu, ... Baoguo **e in Cancer Cell International
    Article Open access 24 September 2022
  14. CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model

    The highly restricted expression of B-cell maturation antigen (BCMA) on plasma cells makes it an ideal target for chimeric antigen receptor (CAR)...

    Yu Yang Ng, Zhicheng Du, ... Shu Wang in Cancer Gene Therapy
    Article 01 September 2021
  15. The cancer–natural killer cell immunity cycle

    Immunotherapy with checkpoint blockade induces rapid and durable immune control of cancer in some patients and has driven a monumental shift in...

    Nicholas D. Huntington, Joseph Cursons, Jai Rautela in Nature Reviews Cancer
    Article 24 June 2020
  16. Natural killer group 2D receptor and its ligands in cancer immune escape

    The immune system plays important roles in tumor development. According to the immune-editing theory, immune escape is the key to tumor survival, and...

    Shixin Duan, Weihua Guo, ... Fuyan Wang in Molecular Cancer
    Article Open access 27 February 2019
  17. Group XIV C-type lectins: emerging targets in tumor angiogenesis

    C-type lectins, distinguished by a C-type lectin binding domain (CTLD), are an evolutionarily conserved superfamily of glycoproteins that are...

    Elliott J. Yee, Isaac Vigil, ... Yuwen Zhu in Angiogenesis
    Article Open access 12 March 2024
  18. Neuroblast senescence in the aged brain augments natural killer cell cytotoxicity leading to impaired neurogenesis and cognition

    Normal aging is accompanied by escalating systemic inflammation. Yet the potential impact of immune homeostasis on neurogenesis and cognitive decline...

    Wei-Na **, Kaibin Shi, ... Qiang Liu in Nature Neuroscience
    Article 30 November 2020
  19. Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer

    Background

    Adoptive cell therapy has achieved great success in treating hematological malignancies. However, the production of chimeric antigen...

    Yan Zhang, Cong Zhang, ... Hai** Zhang in BMC Cancer
    Article Open access 23 January 2024
  20. Blood CD3-(CD56 or 16)+ natural killer cell distributions are heterogeneous in healthy adults and suppressed by azathioprine in patients with ANCA-associated vasculitides

    Background

    Cytotoxic Natural Killer (NK) cells are increasingly recognized as a powerful tool to induce targeted cell death in cancer and autoimmune...

    Wolfgang Merkt, Ulrich Salzer, ... Nils Venhoff in BMC Immunology
    Article Open access 12 April 2021
Did you find what you were looking for? Share feedback.